Skip banner
HomeHow Do I?Site MapHelp
Return To Search FormFOCUS
Search Terms: internet, pharmacy

Document ListExpanded ListKWICFULL format currently displayed

Previous Document Document 2 of 3. Next Document

Locate a Copy of This Publication In Your Library

CIS/Index
Copyright © 2000, Congressional Information Service, Inc.

2000 CIS S 43110

TITLE: E-Drugs: Who Regulates Internet Pharmacies

CIS-NO: 2000-S431-10  
SOURCE: Committee on Health, Education, Labor, and Pensions. Senate  
DOC-TYPE: Hearing Retrieve the full text of testimony  
DOC-NO: S. Hrg. 106-514  
DATE: Mar. 21, 2000  
LENGTH: iii+165 p.  
CONG-SESS: 106-2  
ITEM-NO: 1043-A; 1043-B  
SUDOC: Y4.L11/4:S.HRG.106-514  
MC-ENTRY-NO: 2000-17432  


SUMMARY:
Hearing to review benefits and risks to consumers of pharmaceutical sales over the Internet, and to examine current and proposed regulatory efforts to prevent inappropriate sales of prescription medication online.
 
Supplementary material (p. 156-165) includes a submitted statement.

CONTENT-NOTATION: Pharmaceutical sales on the Internet, regulatory issues

DESCRIPTORS:  
    MEDICAL REGULATION; PHARMACISTS AND PHARMACY; PUBLIC HEALTH; CONSUMERS; INTERNET

00-S431-10 TESTIMONY NO: 1     Mar. 21, 2000 p. 7-33
 
WITNESSES (and witness notations):
   HENNEY, JANE E. (Dr.) (Commissioner, FDA)
   WOODCOCK, JANET (Dr.) (Director, Center for Drug Evaluation and Research)
   TAYLOR, JOHN (Senior Advisor, Regulatory Policy, Office of Regulatory Affairs)
 
STATEMENTS AND DISCUSSION:
   Review of public health risks of Internet pharmaceutical sales, including adverse effects of harmful drug products; overview of FDA efforts to regulate online prescription medication sales.
 
CONTENT NOTATION:
   Pharmaceutical sales on the Internet, regulatory issues
 
TESTIMONY DESCRIPTORS:
   FOOD AND DRUG ADMINISTRATION
 
 
00-S431-10 TESTIMONY NO: 2     Mar. 21, 2000 p. 34-156
 
WITNESSES (and witness notations):
   STOVALL, CARLA J. (Attorney General, Kansas; representing National Association of Attorneys General)
   CATIZONE, CARMEN A. (Executive Director, National Association of Boards of Pharmacy (NABP))
   LEVY, BRUCE A. (Dr.) (Executive Director, Texas Board of Medical Examiners; representing Federation of State Medical Boards (FSMB))
   NEUPERT, PETER (President and CEO, drugstore.com)
   ANTHONY, CALVIN J. (Executive Vice President, National Community Pharmacists Association)
 
STATEMENTS AND DISCUSSION:
   Overview of State and Federal law enforcement issues regarding Internet pharmacy regulation, with recommendations; description of NABP efforts to monitor online medication sales, including the Verified Internet Pharmacy Practice Sites Program granting certification to online pharmacies that comply with State and Federal mandates (related materials, p. 49-124).
   Review of FSMB role in promoting regulatory standards for online pharmacies; description of drugstore.com operations as an Internet licensed pharmaceutical sales company.
 
CONTENT NOTATION:
   Pharmaceutical sales on the Internet, regulatory issues
 
TESTIMONY DESCRIPTORS:
   KANSAS ATTORNEY GENERAL'S OFFICE; LICENSES; STATE LAWS; LAW ENFORCEMENT

LOAD-DATE: July 6, 2001




Locate a Copy of This Publication In Your Library

Previous Document Document 2 of 3. Next Document


FOCUS

Search Terms: internet, pharmacy
To narrow your search, please enter a word or phrase:
   
About LEXIS-NEXIS® Congressional Universe Terms and Conditions Top of Page
Copyright © 2002, LEXIS-NEXIS®, a division of Reed Elsevier Inc. All Rights Reserved.